BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-427@pharmaconomics
DTSTAMP:20260707T034521Z
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260508
SUMMARY:ATRA AdCom — tabelecleucel
DESCRIPTION:An FDA advisory committee reviews tabelecleucel for EBV+ PTLD around May 7\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1604464/000119312526210413/atra-20260507.htm\n\nTrack it: https://www.pharmaconomics.com/e/427
URL:https://www.pharmaconomics.com/e/427
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ATRA catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR